Detalhe da pesquisa
1.
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization.
Immunity
; 55(2): 341-354.e7, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990590
2.
[Development approaches for vaccines against hepatitis C virus infections]. / Entwicklungsansätze für Impfstoffe gegen Hepatitis-C-Virus-Infektionen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(2): 183-191, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-35015104
3.
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies.
Gut
; 70(9): 1734-1745, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33323394
4.
Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.
J Hepatol
; 70(4): 593-602, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30439392
5.
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity.
J Hepatol
; 67(3): 480-489, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438690
6.
Correction for Haid et al., "Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System".
J Virol
; 94(14)2020 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32611690
7.
Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.
J Virol
; 90(6): 3065-73, 2015 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719246
8.
Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.
J Virol
; 88(3): 1433-46, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173232
9.
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
J Virol
; 88(21): 12644-55, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25142595
10.
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.
Hepatology
; 60(5): 1508-18, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797654
11.
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
Gut
; 63(7): 1137-49, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23903236
12.
MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles.
PLoS Pathog
; 8(7): e1002829, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22911431
13.
Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.
Hepatology
; 57(5): 1716-24, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23212706
14.
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.
Hepatology
; 57(2): 492-504, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23081796
15.
Landscape of protein-protein interactions during hepatitis C virus assembly and release.
Microbiol Spectr
; 12(2): e0256222, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230952
16.
A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
Gastroenterology
; 143(1): 213-22.e5, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22465429
17.
Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
J Virol
; 86(2): 991-1000, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072759
18.
Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.
PLoS Pathog
; 6: e1000978, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20617177
19.
Hepatitis C virus plays hide and seek with neutralizing antibodies.
Hepatology
; 64(6): 1840-1842, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515101
20.
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.
J Virol
; 84(11): 5751-63, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20357091